ZIVO BIOSCIENCE, INC. (OTCMKTS:ZIVO) Files An 8-K Other EventsItem 8.01. Other Events.
On January 10, 2018 the Company released its Presentation to the Biotech Showcase at the Hilton San Francisco Union Square hotel on Wednesday, January 10, 2018 during the JPMorgan Healthcare Conference, a copy of which is filed herewith as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
|
Exhibit No. |
Description |
|
99.1 |
Presentation to the Biotech Showcase, dated January 10, 2018. |
Zivo Bioscience, Inc. ExhibitEX-99.1 2 f8k011018_ex99z1.htm EXHIBIT 99.1 PRESENTATION TO THE BIOTECH SHOWCASE,…To view the full exhibit click here
About ZIVO BIOSCIENCE, INC. (OTCMKTS:ZIVO)
Zivo Bioscience, Inc., formerly Health Enhancement Products, Inc., is a biotechnology company. The Company is engaged in the study, development and commercialization of naturally derived compounds and bioactive molecules created by algal and bacterial hosts. The Company focuses on research and identification of its bioactive ingredients. It focuses to sell natural bioactive ingredients derived from its algae cultures to animal, human and dietary supplement and medical food manufacturers. It is also engaged in development of biologically derived and synthetic candidates for medicinal and pharmaceutical applications in humans and animals, specifically focused on autoimmune and inflammatory response modulation. It focuses on developing, manufacturing, marketing and selling tests that allow users to optimize personal health and identify future health risks. The Company manufactures algal products and derivatives, and has various product platforms.
